{[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]methyl}amine hydrochloride, 95.0%, 10g

5-(1H-pyrazol-5-yl)-2-furansulfonyl chloride, 95.0%, 250mg

7-(4-(tert-Butyl)phenyl)-2-methyl-1H-indene, 1g

1-(3-Methoxy-4-nitro-phenyl)-4-methyl-piperidine, 1g

4-(4-Chlorothiophen-2-yl)thiazol-2-amine, 97%, 100g

2-Pyrrolidin-1-yl-isonicotinic acid, 95.0%, 250mg

5H-PYRROLO[1,2-A]QUINOXALIN-4-ONE, 97.0%, 1g

6-(2,6-Dimethoxyphenyl)-6-oxohexanoic acid, 97.0%, 1g

Isochroman-4-ol, 95.0%, 5g

[3-chloro-2-(1-pyrrolidinyl)phenyl]amine dihydrochloride, 95.0%, 1g

2,3,4,5-Tetrahydro-1H-benzo[b]azepin-8-ol, 98%, 50mg

N-Benzyl-4-methyl-N-nitrosobenzenesulfonamide, 95.0%, 250mg

Conjunto de polarización. El analizador se coloca sobre el ocular y una estrecha mesa giratoria de 360° con polarizador incorporado.